Effect of Topical Tranexamic Acid in Acute Spontaneous Epistaxis: A Randomized Controlled Trial
The Laryngoscope · 03.11.2026
DOI: 10.1002/lary.71044 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Laryngoscope, online erschienen am 03.11.2026. Verfasst von Mohammad Reza Majidi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology - Head & Neck Surgery, Mashhad University of Medical Sciences, Mashhad, Iran. Die Arbeit nennt 24 Literaturangaben. Gefördert von: Mashhad University of Medical Sciences.
Abstract (Originalsprache)
Objective
Persistent epistaxis and early rebleeding remain clinical challenges despite the self‐limiting nature of many cases. Identification of a simple, noninvasive strategy for hemostasis and recurrence prevention remains a clinical priority. Topical tranexamic acid (TXA) is a potential hemostatic agent, but evidence regarding its effectiveness, particularly for rebleeding, is limited and inconsistent. This study evaluated the role of topical TXA in controlling bleeding and preventing rebleeding in acute spontaneous epistaxis.
Methods
In this randomized, double‐blind, placebo‐controlled trial, patients presenting with acute spontaneous epistaxis unresponsive to initial first‐aid measures were enrolled and randomly assigned to receive topical tranexamic acid (TXA) or placebo.
Results
A total of 162 patients were included in the study, including 76 in the TXA group and 86 in the control group. Topical TXA was significantly more effective than placebo in achieving initial hemostasis in the emergency department setting ( p = 0.047). No significant differences were observed in rebleeding within 24 h (risk ratio 0.45 (95% CI, 0.17–1.24; p = 0.119)), or in significant rebleeding within 24 h (risk ratio: 1.50 (95% CI, 0.26–8.70; p = 0.651)).
Conclusion
In spontaneous epistaxis, the direct application of topical tranexamic acid to the bleeding site is a useful adjunct for achieving hemostasis. This targeted approach may allow effective bleeding control with a smaller amount of the drug, potentially reducing the risk of adverse effects associated with higher doses. Level of Evidence 1
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology - Head & Neck Surgery, Mashhad University of Medical Sciences, Mashhad, Iran.
ORCID-Profile: Mohammad Reza Majidi, Imaneh Roshanzamir, Ermia Mousavi Mohammadi
Förderung
- Mashhad University of Medical Sciences
Zitieren
APA
Majidi, M. R., Roshanzamir, I., & Mohammadi, E. M. (2026). Effect of Topical Tranexamic Acid in Acute Spontaneous Epistaxis: A Randomized Controlled Trial. The Laryngoscope. https://doi.org/10.1002/lary.71044
Vancouver
Majidi MR, Roshanzamir I, Mohammadi EM. Effect of Topical Tranexamic Acid in Acute Spontaneous Epistaxis: A Randomized Controlled Trial. The Laryngoscope. 2026. doi:10.1002/lary.71044
BibTeX
@article{Majidi2026,
author = {Majidi, Mohammad Reza and Roshanzamir, Imaneh and Mohammadi, Ermia Mousavi},
title = {Effect of Topical Tranexamic Acid in Acute Spontaneous Epistaxis: A Randomized Controlled Trial},
journal = {The Laryngoscope},
year = {2026},
doi = {10.1002/lary.71044}
}
EUVIMED